Bulletin
Investor Alert

Sanofi

OTC: SNYNF

GO
/marketstate/country/us

Market closed

/zigman2/quotes/205505035/delayed

$

97.85

Change

-0.95 -0.96%

Volume

Volume 216

Jan 26, 2023, 9:35 a.m.

Quotes are delayed by 20 min

/zigman2/quotes/205505035/delayed

Previous close

$ 98.80

$ 97.85

Change

-0.95 -0.96%

Day low

Day high

$97.85

$97.85

Open
Open: 97.85

52 week low

52 week high

$73.31

$112.50

Open

Market cap

$121.60B

Average volume

21,569

P/E ratio

16.46

Rev. per Employee

$474,871

EPS

5.95

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/snynf

MarketWatch News on SNYNF

  1. video content The New Doctor in the House: Consolidation

    8:46 a.m. Feb. 1, 2011

    - Barrons.com

  2. Your Money: Pros, cons of paying taxes with a credit card

    12:14 p.m. March 14, 2000

    - CBS.MarketWatch.com

  3. Retail sales roar ahead in February

    11:48 a.m. March 14, 2000

    - CBS.MarketWatch.com

  4. Clueless Investor: Web making muni bonds more accessible to individuals

    10:55 a.m. March 14, 2000

    - CBS.MarketWatch.com

  5. World Markets: Nikkei surrenders morning session's rebound

    2:15 a.m. March 14, 2000

    - Mariko Ando

  6. Michael J. Bazdarich: No need to worry about the 'wealth effect'

    9:13 p.m. March 13, 2000

    - CBS.MarketWatch.com

  7. Washington schedule for March 13-19

    5:44 p.m. March 13, 2000

    - CBS.MarketWatch.com

  8. Joe Battipaglia: Economic data will show that inflation is tame

    11:29 a.m. March 13, 2000

    - CBS.MarketWatch.com

  9. Washington schedule for March 13-19

    12:09 p.m. March 11, 2000

    - CBS.MarketWatch.com

/news/nonmarketwatch/company/us/snynf

Other News on SNYNF

  1. Sanofi wins EU nod for Dupixent to include new skin condition

    7:00 a.m. Nov. 11, 2022

    - Seeking Alpha

  2. Biogen names former Sanofi head Chris Viehbacher as new CEO

    8:18 a.m. Nov. 10, 2022

    - Seeking Alpha

  3. Sanofi: What Has Happened?

    11:38 a.m. Nov. 9, 2022

    - Seeking Alpha

  4. Kymera: Upcoming Trial Data Will Make Or Break The Company

    11:46 a.m. Nov. 8, 2022

    - Seeking Alpha

  5. Pfizer: Q3 Earnings Review - Planning For Life After COVID

    1:17 p.m. Nov. 3, 2022

    - Seeking Alpha

  6. Sanofi SA (SNY) Q3 2022 Earnings Call Transcript

    2:40 p.m. Oct. 28, 2022

    - Seeking Alpha

  7. Regeneron slips as Raymond James downgrades on Eylea concerns

    6:41 a.m. Oct. 26, 2022

    - Seeking Alpha

  8. DTH: Beaten By Inflation

    6:33 a.m. Oct. 3, 2022

    - Seeking Alpha

  9. BioMarin Pharmaceutical: Leader In Rare Disease Innovation

    10:11 p.m. Oct. 2, 2022

    - Seeking Alpha

  10. Exploding EV Competition Could Send Tesla Under $100

    8:22 a.m. Sept. 14, 2022

    - Seeking Alpha

  11. Sanofi: A Nightmarish August To Take Advantage Of

    4:00 p.m. Sept. 9, 2022

    - Seeking Alpha

  12. New York declares polio emergency to improve vaccinations

    11:20 a.m. Sept. 9, 2022

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/snynf

Press Releases on SNYNF

No News currently available for SNYNF

Rates »

Link to MarketWatch's Slice.